Company Profile
Lonza is a contract development and manufacturing organization for pharma and biotech companies globally. Its business is organized into Integrated Biologics. Its portfolio also includes Advanced Synthesis, and Specialized Modalities segments.
The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing operates mammalian and drug product platforms.
Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and bioconjugates, small molecules, and highly potent active pharmaceutical ingredients operates small molecules and bioconjugates platforms.
The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Incorporated in 1897, Lonza is headquartered in Basel, Switzerland.